Study Evaluating the Safety and Efficacy of ERB-041 on Reduction of Symptoms Associated With Endometriosis in Reproductive-Aged Women

NCT00318500 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Dysmenorrhea
Dyspareunia
Endometriosis
Pelvic Pain

Interventions

DRUG: ERB-041

Sponsor

Wyeth is now a wholly owned subsidiary of Pfizer